Funding News Edition: January 08, 2020 See more articles in this edition
Good news, we now have a federal budget appropriation through September 30, 2020, for fiscal year (FY) 2020. Find the full details in the amended H.R. 1865 bill.
NIH receives $41.68 billion in funding, an increase of $2.6 billion from FY 2019. For NIH, the bill includes $500 million for the All of Us precision medicine study, a $25 million increase for HIV/AIDS research, and more as listed in the Summary of H.R. 1865.
Federalwide, the bill includes $291 million to support the Ending the HIV Epidemic: A Plan for America initiative and other high-priority HIV efforts. It also provides $770 million to combat malaria, $310 million for tuberculosis programs, and $102.5 million to combat neglected tropical diseases.
NIAID receives $5.89 billion, up 6.6 percent from FY 2019’s $5.52 billion. It includes $511 million for research related to combating antimicrobial resistance, an increase of $50 million. The appropriation also provides not less than $200 million to advance basic, translational, and clinical research to develop a universal influenza vaccine, an increase of $60 million.
Check the NIAID Financial Management Plan for the latest information on selective pay and R56-Bridge awards.
NIAID Paylines and Budget Information Changes Throughout the Year, most recently on December 23, 2019, when we set an interim NIAID Payline for Research Enhancement Awards (R15): 22 overall impact score. We also have interim paylines for R01, R03, and R21 grant types. To learn of payline updates in the coming months, you can Subscribe to Email Alerts, watch for news in this publication, or follow us on Twitter at @NIAIDFunding.
For additional information about our budget process and timing, see Background on NIAID Funding Opportunity Planning and the Budget Cycle.